Member Info for Mavern

https://www.**********.co.uk/articles/onthemarket-blencowe-resources-vadim-alexandre-on-novacyt-polarean-diurnal-feedback-ce84222/

https://www.proactiveinvestors.co.uk/companies/news/930335/polarean-imaging-to-submit-nda-early-in-october-930335.html

By the time approvals are granted this is likely to be significantly higher than today. Markets are very forward looking and we are now close enough for the re-rate to begin. In face it’s already begun. In addition, big chance of Bracco takeover too, as you alluded to CM94, given the striking similarities to how the Blue Earth Diagnostics takeover played out

Added another 300,000 earlier, now up to 3M. Really like this morning’s EH development, says so much about the calibre and potential of UFO now under Bill Brodie’s leadership.

Looks like we have resumed the next leg up after the recent consolidation :-)

NCYT need to maximise revenues before superior products hit the market in the coming months.

All coming together nicely :-)

3p rise by mid-day. I’ve been in here a year and rarely seen that :-))

My money is in option 3 Jimbo (literally!) I said it in my post early July and still stand by it : Overseas contracts 08 Jul 2020 11:07
The fact that “no sales”have apparently been achieved suggests to me that the entire manufacturing capacity has been earmarked for just a handful of major overseas contracts, and the bureaucracy of finalising the deals is taking a little longer than anticipated. If this was not the case there would surely be a number of smaller contracts announced by now as the product is simply too good for zero sales to be achieved. Would be interesting to know if it’s full steam ahead on manufacturing?

https://www.bbc.com/news/health-54031587 Can see Polarean playing a prominent role here further down the line

Just read your posts Otpsenpai back to early Aug and you’ve been pretty much spot on all the way from the 0.20’s, great analysis :-)

Yes high volume week really, especially 2nd and 4th. Market is late recognising Polarean’s potential in a current and post covid world but certainly early signs it’s getting some scrutiny from savvy investors.

5% dilution by my calculation and all for very positive reasons. Not at all bad as placing a go.

The trial is taking place in Manchester too which is where GDR are located.

Dow’s dropped 450 from its earlier high. Most of that in last couple of hours.

The US markets in general have fallen back quite a bit in the past hour, that probably accounts for much of the fall.

Onwards and upwards from here I think. Given the significant role this technology could play in a later/post Covid environment I’m surprised the market’s only just starting to take notice.

I actually find JH’s posts very informative, his L2 analysis is often spot on :-)

My thoughts too I441. Think we are fast approaching the time when the mid to later stage Covid players come under the spotlight. When it comes to post illness diagnosis/imaging Polarean is in a great position to play a major role. The share price should soon start to reflect this, even if no FDA acceleration.

The fact that “no sales”have apparently been achieved suggests to me that the entire manufacturing capacity has been earmarked for just a handful of major overseas contracts, and the bureaucracy of finalising the deals is taking a little longer than anticipated. If this was not the case there would surely be a number of smaller contracts announced by now as the product is simply too good for zero sales to be achieved. Would be interesting to know if it’s full steam ahead on manufacturing?